68

Hubei Huaqiang High-Tech Co. Ltd. A

688151 · SHG · Healthcare / Medical Instruments & Supplies

14.95CNY-0.60 (-3.86%)

Price History

Full chart

Market Stats

Previous Close15.55
Open15.46
Day Range14.90 – 15.56
52-Week Range13.68 – 24.06
Volume2.86M
Market Cap5.74B
P/E (TTM)118.93
Forward P/E0.00
EPS0.14
Dividend Yield0.34%
Beta0.51
50-Day Avg16.43
200-Day Avg18.85

About

Hubei Huaqiang High-Tech Co., Ltd. research, develops, produces, and sells pharmaceutical packaging, medical devices, and special protective equipment in China. It operates as a chemical defense military enterprise in special protection. The company offers personal protective equipment, such as gas suits, gas masks, protective clothing, gas gloves, gas boot covers, and airtightness testing instruments; collective protective equipment, comprising collaborative supporting products and products for disarmament troops, pre-filters, air inlet components, particle filters, filter absorbers, filter ventilation devices, and collective protection system equipment; and chemical defense equipment for national civil air defense projects, such as civil air defense filters and doors, impregnated charcoal, and other products. It also provides pharmaceutical packaging and medical devices, such as medicinal butyl rubber stoppers, multi-layer co-extruded films, aluminum-plastic caps, medical masks, and medical protective clothing; standard and coated stoppers, and pre-filled syringe rubber components; and disposable medical protective clothing, disposable medical masks, medical surgical masks, and other medical protective equipment. Hubei Huaqiang High-Tech Co., Ltd. was founded in 2001 and is headquartered in Yichang, China.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. Banglao Liu
  • Employees614
  • HeadquartersNo. 499, Donglin Road, Yichang, China, 443000, China
  • Websitehttps://www.hqtc.com

Leadership

  • Mr. Banglao LiuGM & Director · b. 1979
  • Mr. Yan SunBoard Secretary and Chief Accountant & Chief Legal Counsel · b. 1973
  • Mr. Jie ChenExecutive Deputy Director of Technology Center · b. 1984
  • Mr. Chao ZhouDeputy General Manager · b. 1982
  • Mr. Guoqing TangDeputy General Manager · b. 1984
  • Ms. Jing YangDeputy Director of Technology Center · b. 1985
  • Mr. Junxiong TangAssistant General Manager & Director of Technology Center · b. 1973
  • Mr. De'an ChenDeputy General Manager · b. 1973
  • Mr. Huashan HeDeputy Director of Science & Technology Committee · b. 1965

Financials

Income Statement

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.65B835.12M1.27B585.68M572.75M611.35M628.32M
Growth (%)--49.31%+52.64%-54.05%-2.21%+6.74%+2.78%
Cost of Revenue1.33B571.22M730.22M450.26M489.72M511.58M471.72M
Gross Profit316.49M263.89M544.50M135.42M83.03M99.76M156.60M
Gross Margin19.21%31.60%42.72%23.12%14.50%16.32%24.92%
Operating Expense145.24M137.25M145.75M144.99M125.00M142.90M145.13M
Operating Income171.25M126.65M398.75M-9.57M-41.97M-43.14M11.47M
Operating Margin10.39%15.16%31.28%-1.63%-7.33%-7.06%1.82%
EBITDA173.34M238.39M424.93M117.69M61.38M78.14M100.11M
EBITDA Margin10.52%28.55%33.34%20.09%10.72%12.78%15.93%
Net Income130.08M176.20M319.19M68.07M7.93M22.53M42.78M
Net Income Margin7.90%21.10%25.04%11.62%1.38%3.68%6.81%
R&D44.06M39.62M58.92M66.39M51.75M56.60M58.17M
R&D as % of Total Revenue2.67%4.74%4.62%11.34%9.03%9.26%9.26%
Interest Expense1.71M834.24K775.47K145.94K122.17K137.36K64.77K
Interest Expense % of Total Revenue0.10%0.10%0.06%0.02%0.02%0.02%0.01%

Balance Sheet

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets2.20B2.31B5.29B5.16B5.05B4.88B4.81B
Total Liabilities1.25B1.15B1.06B974.43M881.39M680.27M584.78M
Total Equity950.04M1.16B4.23B4.19B4.17B4.20B4.23B
Cash856.03M606.53M3.64B2.55B2.41B1.85B2.52B

Cash Flow

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow440.81M-313.12M472.43M-181.30M-66.88M-137.75M36.35M
Capital Expenditure147.45M124.60M41.38M43.51M57.87M44.28M30.73M
Free Cash Flow293.36M-437.72M431.05M-224.82M-124.75M-182.03M5.63M
Dividends Paid26.73M26.38M64.17M115.41M26.08M8.20M49.14M
FCF to OCF66.55%139.79%91.24%124.00%186.54%132.14%15.48%
Dividend Paid to FCF9.11%-6.03%14.89%-51.33%-20.91%-4.50%873.17%

Earnings

Report DateMar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023
EPS Estimate-----
EPS Actual0.220.060.01-0.080.05
Surprise-----
Timing-----

Key Statistics & Ratios

Market Cap5.74B
Enterprise Value3.36B
Trailing P/E118.93
Forward P/E0.00
Price / Sales8.57
Price / Book1.39
EPS0.14
Book Value12.24
Revenue (TTM)669.57M
Gross Profit (TTM)164.02M
EBITDA6.97M
Profit Margin7.19%
Operating Margin-25.72%
Return on Equity1.15%
Return on Assets-0.59%
Shares Outstanding344.50M
Shares Float91.71M
Beta0.51
Dividend Yield0.34%
Dividend Rate0.06
Payout Ratio40.00%

Dividends

20262×
0.01Nov 4, 20260.06Jun 18, 2026
20251×
0.04May 29, 2025
20242×
0.02Oct 30, 20240.01Jul 11, 2024
20231×
0.08Jul 7, 2023
20221×
0.34Jun 15, 2022